GranuFlo Manufacturer Allegedly Failed to Warn
There have been an increasing number of lawsuits filed against Fresenius, the manufacturer of the GranuFlo dialysis treatment, based on serious health problems following use of the product. GranuFlo is a dialysate that is used during hemodialysis to offset the acid created by kidney failure. The acting agent within the product can convert to dangerously high levels of sodium which often cause serious heart problems.
Individuals seriously injured following the use of GranuFlo have filed suit in courts all across the country. With Fresenius serving up to one-third of Americans requiring dialysis, it is expected for that number to only rise as patients and families learn of the high risks associated with GranuFlo.
Recent suits have highlighted the damage caused by GranuFlo. Last month, an individual filed suit seeking $6 million from Fresenius after suffering cardiac arrest and other ongoing serious health problems allegedly as a result of using GranuFlo. The plaintiff is seeking compensation for medical expenses and legal costs, pain and suffering, emotional distress, as well as lost wages and earnings.
After beginning hemodialysis in 2008, the plaintiff experienced cardiac arrest in 2010 and subsequently required surgery to fit a pacemaker. The plaintiff alleges that Fresenius failed to adequately warn consumers and the medical field of the full extent of risks associated with GranuFlo.
Other recently filed Tennessee GranuFlo lawsuits involve wrongful death actions as a result of the deceased using product during dialysis. One of the lawsuits involves two sisters filing on behalf of their late mother, while another suit involves a widow seeking compensation following the death of her husband. These lawsuits are the only recourse for families heavily burdened from the fatal effects of GranuFlo.
If you have questions regarding potential injuries related to this product please feel free to contact one of your Nashville GranuFlo injury lawyers today.